Đang chuẩn bị liên kết để tải về tài liệu:
Fluoroquinolone resistance in bacteremic and low risk febrile neutropenic patients with cancer

The low risk febrile neutropenic patients with Multinational Association for Supportive Care in Cancer (MASCC) score of more than 20 are recommended to be treated with fluoroquinolone-based oral treatment by the National Comprehensive Cancer Network (NCCN) guideline. |